Analystreport

Cellectar Biosciences Inc (NASDAQ: CLRB) is now covered by analysts at Maxim Group. They set a "buy" rating on the stock.

Cellectar Biosciences, Inc.  (CLRB) 
Last cellectar biosciences, inc. earnings: 11/12 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.cellectar.com